KRYS logo

Krystal Biotech (KRYS) Cash from operations

annual CFO:

$123.42M+$212.22M(+238.98%)
December 31, 2024

Summary

  • As of today (June 26, 2025), KRYS annual cash flow from operations is $123.42 million, with the most recent change of +$212.22 million (+238.98%) on December 31, 2024.
  • During the last 3 years, KRYS annual CFO has risen by +$171.36 million (+357.46%).
  • KRYS annual CFO is now at all-time high.

Performance

KRYS Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKRYScash flow metrics

quarterly CFO:

$30.97M-$21.87M(-41.39%)
March 31, 2025

Summary

  • As of today (June 26, 2025), KRYS quarterly cash flow from operations is $30.97 million, with the most recent change of -$21.87 million (-41.39%) on March 31, 2025.
  • Over the past year, KRYS quarterly CFO has increased by +$15.08 million (+94.92%).
  • KRYS quarterly CFO is now -47.38% below its all-time high of $58.86 million, reached on September 30, 2024.

Performance

KRYS quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKRYScash flow metrics

TTM CFO:

$138.50M+$15.08M(+12.22%)
March 31, 2025

Summary

  • As of today (June 26, 2025), KRYS TTM cash flow from operations is $138.50 million, with the most recent change of +$15.08 million (+12.22%) on March 31, 2025.
  • Over the past year, KRYS TTM CFO has increased by +$185.26 million (+396.20%).
  • KRYS TTM CFO is now at all-time high.

Performance

KRYS TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKRYScash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

KRYS Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+239.0%+94.9%+396.2%
3 y3 years+357.5%+299.9%+357.6%
5 y5 years+760.4%+597.3%+738.2%

KRYS Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+222.7%-47.4%+171.9%at high+224.5%
5 y5-yearat high+222.7%-47.4%+171.9%at high+224.5%
alltimeall timeat high+222.7%-47.4%+171.9%at high+224.5%

KRYS Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
$30.97M(-41.4%)
$138.50M(+12.2%)
Dec 2024
$123.42M(-239.0%)
$52.84M(-10.2%)
$123.42M(+94.8%)
Sep 2024
-
$58.86M(-1512.1%)
$63.34M(-478.5%)
Jun 2024
-
-$4.17M(-126.2%)
-$16.74M(-64.2%)
Mar 2024
-
$15.89M(-319.7%)
-$46.76M(-47.3%)
Dec 2023
-$88.80M(-11.7%)
-$7.23M(-65.9%)
-$88.80M(-14.5%)
Sep 2023
-
-$21.23M(-37.9%)
-$103.90M(+1.5%)
Jun 2023
-
-$34.19M(+30.7%)
-$102.36M(-8.0%)
Mar 2023
-
-$26.16M(+17.1%)
-$111.23M(+10.6%)
Dec 2022
-$100.57M(+109.8%)
-$22.33M(+13.4%)
-$100.57M(+1.4%)
Sep 2022
-
-$19.69M(-54.3%)
-$99.14M(+14.3%)
Jun 2022
-
-$43.06M(+177.9%)
-$86.71M(+61.2%)
Mar 2022
-
-$15.49M(-25.9%)
-$53.78M(+12.2%)
Dec 2021
-$47.94M(+83.8%)
-$20.90M(+188.1%)
-$47.94M(+36.7%)
Sep 2021
-
-$7.25M(-28.4%)
-$35.06M(+1.4%)
Jun 2021
-
-$10.13M(+4.9%)
-$34.59M(+17.2%)
Mar 2021
-
-$9.65M(+20.3%)
-$29.51M(+13.1%)
DateAnnualQuarterlyTTM
Dec 2020
-$26.08M(+39.6%)
-$8.02M(+18.4%)
-$26.08M(+4.1%)
Sep 2020
-
-$6.78M(+34.1%)
-$25.06M(+11.1%)
Jun 2020
-
-$5.05M(-18.8%)
-$22.55M(+3.9%)
Mar 2020
-
-$6.23M(-11.0%)
-$21.70M(+16.1%)
Dec 2019
-$18.69M(+97.9%)
-$7.00M(+64.1%)
-$18.69M(+22.9%)
Sep 2019
-
-$4.27M(+1.4%)
-$15.21M(+18.1%)
Jun 2019
-
-$4.21M(+30.9%)
-$12.88M(+25.2%)
Mar 2019
-
-$3.21M(-8.6%)
-$10.29M(+9.0%)
Dec 2018
-$9.45M(+142.8%)
-$3.52M(+81.3%)
-$9.45M(+17.3%)
Sep 2018
-
-$1.94M(+19.9%)
-$8.05M(+11.7%)
Jun 2018
-
-$1.62M(-31.7%)
-$7.21M(+20.2%)
Mar 2018
-
-$2.37M(+11.4%)
-$6.00M(+54.3%)
Dec 2017
-$3.89M(+196.7%)
-$2.13M(+93.7%)
-$3.89M(+120.6%)
Sep 2017
-
-$1.10M(+169.1%)
-$1.76M(+165.1%)
Jun 2017
-
-$408.00K(+58.8%)
-$665.00K(+158.8%)
Mar 2017
-
-$257.00K
-$257.00K
Dec 2016
-$1.31M
-
-

FAQ

  • What is Krystal Biotech annual cash flow from operations?
  • What is the all time high annual CFO for Krystal Biotech?
  • What is Krystal Biotech annual CFO year-on-year change?
  • What is Krystal Biotech quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Krystal Biotech?
  • What is Krystal Biotech quarterly CFO year-on-year change?
  • What is Krystal Biotech TTM cash flow from operations?
  • What is the all time high TTM CFO for Krystal Biotech?
  • What is Krystal Biotech TTM CFO year-on-year change?

What is Krystal Biotech annual cash flow from operations?

The current annual CFO of KRYS is $123.42M

What is the all time high annual CFO for Krystal Biotech?

Krystal Biotech all-time high annual cash flow from operations is $123.42M

What is Krystal Biotech annual CFO year-on-year change?

Over the past year, KRYS annual cash flow from operations has changed by +$212.22M (+238.98%)

What is Krystal Biotech quarterly cash flow from operations?

The current quarterly CFO of KRYS is $30.97M

What is the all time high quarterly CFO for Krystal Biotech?

Krystal Biotech all-time high quarterly cash flow from operations is $58.86M

What is Krystal Biotech quarterly CFO year-on-year change?

Over the past year, KRYS quarterly cash flow from operations has changed by +$15.08M (+94.92%)

What is Krystal Biotech TTM cash flow from operations?

The current TTM CFO of KRYS is $138.50M

What is the all time high TTM CFO for Krystal Biotech?

Krystal Biotech all-time high TTM cash flow from operations is $138.50M

What is Krystal Biotech TTM CFO year-on-year change?

Over the past year, KRYS TTM cash flow from operations has changed by +$185.26M (+396.20%)
On this page